Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-06-0616
European Journal of Endocrinology, Vol 156, Issue 3, 303-308
Copyright © 2007 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Illouz, F.
Right arrow Articles by Rohmer, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Illouz, F.
Right arrow Articles by Rohmer, V.

CLINICAL STUDY

Usefulness of repeated fine-needle cytology in the follow-up of non-operated thyroid nodules

Frédéric Illouz1,5, Patrice Rodien1,5,6, Jean Paul Saint-André2,5, Stéphane Triau2, Sandrine Laboureau-Soares1, Séverine Dubois1, Bruno Vielle3, Hamy Antoine4,5 and Vincent Rohmer1,5,6

1 Département d’Endocrinologie, CHU d’Angers, Angers, France, 2 Département d’Anatomo-Pathologie, CHU d’Angers, Angers, France, 3 Département de Biostatistiques, CHU d’Angers, Angers, France, 4 Département de Chirurgie générale, CHU d’Angers, Angers, France, 5 Université d’Angers, Angers, France and 6 INSERM U694, Angers, France

(Correspondence should be addressed to F Illouz who is now at Département d’Endocrinologie, CHU d’Angers, 4 rue Larrey, 49933 Angers cedex 9, France; Email: frillouz{at}chu-angers.fr)

Objective: The usefulness of repeated fine-needle cytology (FNC) in thyroid nodules with benign cytology remains unknown. We analyzed the relevance of repeated FNC to detect suspicious or malignant (S/M) cytologies and carcinomas.

Design: A retrospective study (1983–2004) was conducted in our endocrinology department.

Methods: We reviewed the reports of 895 adequate FNC performed in 298 patients (298 nodules) during a mean follow-up of 5 years. We compared the nodules with at least one suspicious or malignant FNC (S/M nodules) with nodules with repeatedly benign (RB) FNC (RB nodules).

Results: Among the nodules with initial benign cytology, we found 35 nodules with one or more later suspicious or malignant results. The interval between the first FNC and the first S/M FNC was 2.9 years. The probability for a nodule to have a repeated benign FNC decreases with time and with the number of FNC. We did not find any clinical or ultrasonographic characteristics related to an S/M cytology. Seven cancers were detected by the second or the third FNC with S/M results. The proportion of cancers among S/M nodules was similar when S/M cytology appears during the first, the second, or the third FNC.

Conclusions: We suggest to repeat FNC up to three adequate samples in the follow-up of thyroid nodules so as not to miss the presence of malignant neoplasm.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 European Society of Endocrinology.